Phathom Pharmaceuticals Statistics
Total Valuation
PHAT has a market cap or net worth of $605.65 million. The enterprise value is $975.20 million.
| Market Cap | 605.65M |
| Enterprise Value | 975.20M |
Important Dates
The next estimated earnings date is Thursday, October 29, 2026, before market open.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PHAT has 79.43 million shares outstanding. The number of shares has increased by 11.72% in one year.
| Current Share Class | 79.43M |
| Shares Outstanding | 79.43M |
| Shares Change (YoY) | +11.72% |
| Shares Change (QoQ) | +2.07% |
| Owned by Insiders (%) | 3.85% |
| Owned by Institutions (%) | 69.68% |
| Float | 63.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.53 |
| Forward PS | 1.53 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92
| Current Ratio | 1.92 |
| Quick Ratio | 1.82 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.64 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -8.80% |
| Return on Invested Capital (ROIC) | -13.50% |
| Return on Capital Employed (ROCE) | -23.45% |
| Weighted Average Cost of Capital (WACC) | 7.99% |
| Revenue Per Employee | $645,989 |
| Profits Per Employee | -$267,040 |
| Employee Count | 371 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 7.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.94% in the last 52 weeks. The beta is 0.50, so PHAT's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -40.94% |
| 50-Day Moving Average | 8.20 |
| 200-Day Moving Average | 11.01 |
| Relative Strength Index (RSI) | 46.99 |
| Average Volume (20 Days) | 1,385,887 |
Short Selling Information
The latest short interest is 10.11 million, so 12.73% of the outstanding shares have been sold short.
| Short Interest | 10.11M |
| Short Previous Month | 10.16M |
| Short % of Shares Out | 12.73% |
| Short % of Float | 15.82% |
| Short Ratio (days to cover) | 8.00 |
Income Statement
In the last 12 months, PHAT had revenue of $239.66 million and -$99.07 million in losses. Loss per share was -$1.27.
| Revenue | 239.66M |
| Gross Profit | 198.73M |
| Operating Income | -40.64M |
| Pretax Income | -99.07M |
| Net Income | -99.07M |
| EBITDA | -40.13M |
| EBIT | -40.64M |
| Loss Per Share | -$1.27 |
Balance Sheet
The company has $182.48 million in cash and $552.02 million in debt, with a net cash position of -$369.55 million or -$4.65 per share.
| Cash & Cash Equivalents | 182.48M |
| Total Debt | 552.02M |
| Net Cash | -369.55M |
| Net Cash Per Share | -$4.65 |
| Equity (Book Value) | -344.27M |
| Book Value Per Share | -4.30 |
| Working Capital | 142.14M |
Cash Flow
In the last 12 months, operating cash flow was -$36.69 million and capital expenditures -$219,000, giving a free cash flow of -$36.91 million.
| Operating Cash Flow | -36.69M |
| Capital Expenditures | -219,000 |
| Depreciation & Amortization | 508,000 |
| Net Borrowing | -55.80M |
| Free Cash Flow | -36.91M |
| FCF Per Share | -$0.46 |
Margins
Gross margin is 82.92%, with operating and profit margins of -16.96% and -41.34%.
| Gross Margin | 82.92% |
| Operating Margin | -16.96% |
| Pretax Margin | -41.34% |
| Profit Margin | -41.34% |
| EBITDA Margin | -16.75% |
| EBIT Margin | -16.96% |
| FCF Margin | n/a |
Dividends & Yields
PHAT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -11.72% |
| Shareholder Yield | -11.72% |
| Earnings Yield | -16.33% |
| FCF Yield | -6.08% |
Analyst Forecast
The average price target for PHAT is $20.09, which is 163.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $20.09 |
| Price Target Difference | 163.48% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 57.24% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PHAT has an Altman Z-Score of -4.9 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.9 |
| Piotroski F-Score | 3 |